SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-16-019444
Filing Date
2016-12-15
Accepted
2016-12-15 14:14:37
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM F-1 ff12016a4_therapixbio.htm F-1/A 109349
2 OPINION OF HORN & CO. - LAW OFFICES ff12016a4ex5i_therapixbio.htm EX-5.1 16523
3 OPINION OF ZYSMAN, AHARONI, GAYER AND SULLIVAN & WORCESTER LLP. ff12016a4ex5ii_therapixbio.htm EX-5.2 13608
4 GRAPHIC ex5ii_001.jpg GRAPHIC 15134
5 GRAPHIC ex5i_001.jpg GRAPHIC 9678
6 GRAPHIC ex5i_002.jpg GRAPHIC 11015
  Complete submission text file 0001213900-16-019444.txt   190258
Mailing Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002
Business Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002 972-8-9396577
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-1/A | Act: 33 | File No.: 333-214458 | Film No.: 162053368
SIC: 2834 Pharmaceutical Preparations